Requires equitable cost sharing for cancer patients no matter the form of medication they receive. This act requires health plans for public employees to cover oral and intravenous cancer-growth medications in a comparable manner. This act takes effect January 1, 2012.   Official Text and Analysis.

To change the category of medications to which the bill applies from "orally administered" medications to "self administered" medications, requires health plans to offer self administered drugs on a basis at least comparable to chemotherapy medications administered by health providers or facilities (the original bill required the medications to be offered on a comparable basis to chemotherapy medications administered intravenously or by injection) and allows health plans to administer a formulary or preferred drug list.

To limit the comparable coverage requirement for selfadministered anticancer drugs to health plans that cover selfadministered chemotherapy drugs, instead of health carriers that cover chemotherapy. States that the act does not require health plans to use self administered medication as a replacement for other cancer medications. Makes changes to the effect statement.

To require health plans that cover chemotherapy treatment to provide coverage for self-administered chemotherapy drugs on a basis at least comparable to drugs administered by a provider or facility.

To add a requirement for each health plan offering individual or small group products that provides coverage for prescribed, self-administered anticancer medication as required by this act must report to the Health Committees of the Legislature by November 1, 2013, with a summary of their cost experience.

Changes the category of medications to which the bill applies from "orally administered" medications to "self administered" medications, requires health plans to offer self administered drugs on a basis at least comparable to chemotherapy medications administered by health providers or facilities (the original bill required the medications to be offered on a comparable basis to chemotherapy medications administered intravenously or by injection) and allows health plans to administer a formulary or preferred drug list. This bill requires health plans that cover chemotherapy treatment to provide coverage for self-administered chemotherapy drugs on a basis at least comparable to drugs administered by a provider or facility. This bill each health plan offering individual or small group products that provides coverage for prescribed, self-administered anticancer medication as required by this act must report to the Health Committees of the Legislature by November 1, 2013, with a summary of their cost experience.

House concurred with Senate amendments. This bill changes the category of medications to which the bill applies from "orally administered" medications to "self administered" medications, requires health plans to offer self administered drugs on a basis at least comparable to chemotherapy medications administered by health providers or facilities (the original bill required the medications to be offered on a comparable basis to chemotherapy medications administered intravenously or by injection) and allows health plans to administer a formulary or preferred drug list. This bill requires health plans that cover chemotherapy treatment to provide coverage for self-administered chemotherapy drugs on a basis at least comparable to drugs administered by a provider or facility. This bill each health plan offering individual or small group products that provides coverage for prescribed, self-administered anticancer.

Changes the category of medications to which the bill applies from "orally administered" medications to "self administered" medications, requires health plans to offer self administered drugs on a basis at least comparable to chemotherapy medications administered by health providers or facilities (the original bill required the medications to be offered on a comparable basis to chemotherapy medications administered intravenously or by injection) and allows health plans to administer a formulary or preferred drug list. This bill requires health plans that cover chemotherapy treatment to provide coverage for self-administered chemotherapy drugs on a basis at least comparable to drugs administered by a provider or facility. This bill each health plan offering individual or small group products that provides coverage for prescribed, self-administered anticancer.